TWA
LEGN icon

TCI Wealth Advisors’s Legend Biotech LEGN Stock Holding History

TCI Wealth Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-75
Closed -$3.74K – 2587
2022
Q4 		$3.74K Buy
+75
New +$3.63K ﹤0.01% 1721

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

TCI Wealth Advisors's LEGN Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Legend Biotech (LEGN) in Q1 2023, closing a stake of 75 shares — an estimated $3.74K sold.

TCI Wealth Advisors first reported a position in LEGN in Q4 2022 and held it in 1 quarter. The position peaked at $3.74K in Q4 2022. 160 funds tracked by Wall St. Rank hold LEGN as of Q1 2023.

  • TCI Wealth Advisors reported no remaining Legend Biotech position as of Q1 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 75 Legend Biotech shares in Q1 2023, an estimated $3.74K.
  • TCI Wealth Advisors first reported a position in Legend Biotech in Q4 2022 and held it in 1 quarter.
  • TCI Wealth Advisors's Legend Biotech position peaked at $3.74K in Q4 2022.
  • 160 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.